ChemicalBook >> CAS DataBase List >>BMS-986034 >=98% (HPLC)

BMS-986034 >=98% (HPLC)

BMS-986034 >=98% (HPLC) structure

CAS No.: 1492631-88-5

Chemical Name:: BMS-986034 >=98% (HPLC)

Synonyms: BMS-986034;BMS-986034 >=98% (HPLC);[1(2H),2'-Bipyridin]-2-one, 5-chloro-4-[[1-(5-chloro-2-pyrimidinyl)-4-piperidinyl]oxy]-5'-[(3R)-3-hydroxy-2-oxo-1-pyrrolidinyl]-6'-methyl-

CBNumber:: CB28323523

Molecular Formula:: C24H24Cl2N6O4

Molecular Weight:: 531.39

MDL Number:: MFCD30718576

MOL File:: 1492631-88-5.mol

MSDS File:: SDS

TDS File:: TDS

Last updated:2026-04-24 14:58:42

Request For Quotation

BMS-986034 >=98% (HPLC) Properties

Boiling point	875.0±75.0 °C(Predicted)
Density	1.55±0.1 g/cm3(Predicted)
storage temp.	room temp
solubility	DMSO: 5mg/mL, clear (warmed)
pka	13.14±0.20(Predicted)
form	powder
color	white to beige
SMILES	ClC(C(OC1CCN(C2=NC=C(Cl)C=N2)CC1)=C3)=CN(C4=NC(C)=C(N5C([C@H](O)CC5)=O)C=C4)C3=O
UNSPSC Code	12352200
NACRES	NA.77

SAFETY

Risk and Safety Statements

WGK Germany	WGK 3
Storage Class	13 - Non Combustible Solids

BMS-986034 >=98% (HPLC) Chemical Properties, Uses, Production

Description

BMS-986034 is a GPR119 agonist.

Uses

BMS-986034 is an orally active ingredient (API) that is an agonist of GPR119.[1].

References

[1] Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions

BMS-986034 >=98% (HPLC) Preparation Products And Raw materials

Raw materials

Preparation Products

BMS-986034 >=98% (HPLC) Suppliers

Global Suppliers ( 3)

Supplier	Tel	Email	Country	ProdList	Advantage
Energy Chemical	400-0056266	marketing1@energy-chemical.com	China	44927	58
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	29874	58

Supplier	Advantage
Energy Chemical	58
TargetMol Chemicals Inc.	58

1492631-88-5 (BMS-986034 >=98% (HPLC)) Related Search:

1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[3-[4-(3-phenyl-1,2,4-oxadiazol-5-yl)-1-piperazinyl]propyl]-, hydrochloride (1:1) Furo[3,2-d]pyrimidine, 7-[1-(5-chloro-2-pyrimidinyl)-4-piperidinyl]-4-[2,3-dihydro-5-(methylsulfonyl)-1H-indol-1-yl]- 2-[hydroxy-[2-hydroxy-3-[(E)-octadec-9-enoyl]oxy-propoxy]phosphoryl]oxyethyl-trimethyl-azanium 2-[4-[3-[3,5-Difluoro-4-[5-(1-methylethyl)-1,2,4-oxadiazol-3-yl]phenoxy]propyl]-1-piperidinyl]-5-ethylpyrimidine 2-MONOOLEIN

4-Piperidinebutanoic acid, 1-(2-cyclobutyl-5,7-dihydro-6,6-dioxidothieno[3,4-d]pyrimidin-4-yl)-

1of2

BMS-986034 >=98% (HPLC) [1(2H),2'-Bipyridin]-2-one, 5-chloro-4-[[1-(5-chloro-2-pyrimidinyl)-4-piperidinyl]oxy]-5'-[(3R)-3-hydroxy-2-oxo-1-pyrrolidinyl]-6'-methyl- BMS-986034 1492631-88-5